Logo

Nasdaq Gives Genomic Solutions 90 Days to Shape Up

Jun 14, 2002

NEW YORK, June 14 - The Nasdaq market has issued Genomic Solutions a "deficiency notice" because its stock has failed to stay above $1 for 30 consecutive days, the company said today.

 

Genomic Solutions said the notice does not affect its stock, which was trading at $.72 this afternoon.

 

The company has 90 days to bring the stock to $1, for which it said it is "evaluating alternatives."

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.